PharVision Advisers’s Palomar PLMR Stock Holding History

PharVision Advisers’s Portfolio PLMR Stock Details PLMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,451	Closed	-$286K	–	933
2025 Q3	$286K	Buy	+2,451	New	+$311K	0.16%	255

Other funds holding PLMR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PharVision Advisers's PLMR Position: Q4 2025 in Review

PharVision Advisers sold out of Palomar (PLMR) in Q4 2025, closing a stake of 2,451 shares — an estimated $286K sold.

PharVision Advisers first reported a position in PLMR in Q3 2025 and held it in 1 quarter. The position peaked at $286K in Q3 2025. 340 funds tracked by Wall St. Rank hold PLMR as of Q4 2025.

PharVision Advisers reported no remaining Palomar position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 2,451 Palomar shares in Q4 2025, an estimated $286K.
PharVision Advisers first reported a position in Palomar in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Palomar position peaked at $286K in Q3 2025.
340 funds tracked by Wall St. Rank held Palomar as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.